Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat

Transplantation Proceedings

Volumn 46, Issue 5, 2014, Pages 1578-1584

  Iwai, S ^a   Sakonju, I ^a   Okano, S ^a   Teratani, T ^b   Kasahara, N ^b   Yokote, S ^c   Yokoo, T ^c   Kobayash, E ^b  

^a KITASATO UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CADAVER DONOR; CARCINOGENESIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; END STAGE RENAL DISEASE; EX VIVO STUDY; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HISTOLOGY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; UREA NITROGEN BLOOD LEVEL; ANIMAL; CYTOLOGY; DEATH; DONOR; KIDNEY; LEWIS RAT; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; DEATH; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, INBRED LEW; TISSUE DONORS;

EID: 84902455645     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.12.068     Document Type: Article

References (54)

1. R.A. Wolfe, V.B. Ashby, and E.L. Milford et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N Engl J Med 341 1999 1725 1730
2. B.M. Shrestha Strategies for reducing the renal transplant waiting list: a review Exp Clin Transplant 7 2009 173 179
3. X.F. Yang, X. He, and J. He et al. High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells J Biomed Sci 18 2011 59
4. E.A. Pomfret, R.S. Sung, and J. Allan et al. Solving the organ shortage crisis: the 7th 332 annual American Society of Transplant Surgeon's 333 State-of-the-Art Winter Symposium Am J Transplant 8 2008 745 752
5. B. Domínguez-Gil, B. Haase-Kromwijk, and H. Van Leiden et al. Current situation of donation after circulatory death in European countries Transpl Int 24 2011 676 686
6. J.M. Kim, S.J. Kim, and J.W. Joh et al. Kidney donation after cardiac death in Korea Transplant Proc 43 2011 1434 1437
7. Z. Liu, B. Zhu, and P. Yun et al. Are we ready to utilize non-heart-beating donors for clinical allotransplantation in China? Transplant Proc 40 2008 1018 1020
8. R.P. Singh, A.C. Farney, and J. Rogers et al. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed function on post-transplant outcomes Clin Transplant 25 2011 255 264
9. J.J. Renkens, M.M. Rouflart, and M.H. Christiaans et al. Outcome of non-heart-beating donor kidneys with prolonged delayed graft function after transplantation Am J Transplant 5 2005 2704 2709
10. N. Perico, D. Cattaneo, and M.H. Sayegh et al. Delayed graft function in kidney transplantation Lancet 364 2004 1814 1827
11. S.G. Yarlagadda, S.G. Coca, and R.N. Formica et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis Nephrol Dial Transplant 24 2009 1039 1047
12. E.K. Geissler The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cells Transplant Res 1 2012 11
13. M. Dominici, K. Le Blanc, and I. Mueller et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
14. M.F. Pittenger, A.M. Mackay, and S.C. Beck et al. Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
15. P.A. Zuk, M. Zhu, and H. Mizuno et al. Multilineage cells from human adipose tissue: implications for cell-based therapies Tissue Eng 7 2001 211 228
16. H. Kanazawa, Y. Fujimoto, and T. Teratani et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model PLoS One 6 2011 e19195
17. N. Kasahara, T. Teratani, and J. Doi et al. Use of mesenchymal stem cell-conditionedmedium to activate islets in preservation solution Cell Med 5 2013 83 87
18. M. Baddoo, K. Hill, and R. Wilkinson et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection J Cell Biochem 89 2003 1235 1249
19. Y. Jiang, B.N. Jahagirdar, and R.L. Reinhardt et al. Pluripotency of mesenchymal stem cells derived from adult marrow Nature 418 2002 41 49
20. S. Wislet-Gendebien, P. Leprince, and G. Moonen et al. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells J Cell Sci 116 2003 3295 3302
21. S. Song, S. Kamath, and D. Mosquera et al. Expression of brain natriuretic peptide by human bone marrow stromal cells Exp Neurol 185 2004 191 197
22. H. Mizuno Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials Curr Opin Mol Ther 12 2010 442 449
23. D. Furlani, M. Ugurlucan, and L. Ong et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy Microvasc Res 77 2009 370 376
24. J. Gao, J.E. Dennis, R.F. Muzic, and M. Lundberg et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion Cells Tissues Organs 169 2001 12 20
25. D. Cyranoski Korean deaths spark inquiry Nature 468 2010 485
26. K. Tatsumi, K. Ohashi, and Y. Matsubara et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism Biochem Biophys Res Commun 431 2013 203 209
27. S. Pratschke, M. Eder, and M. Heise et al. Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion Transplant Res 2 2013 3
28. S. Iwai, T. Kikuchi, and N. Kasahara et al. Impact of normothermic preservation with extracellular type solution containing trehalose on rat kidney grafting from a cardiac death donor PLoS One 7 2012 e33157
29. J. Kaimori, S. Iwai, and M. Hatanaka et al. Non-invasive magnetic resonance imaging in rats for prediction of the fate of grafted kidneys from cardiac death donors PLoS One 8 2013 e63573
30. T. Teratani, and E. Kobayashi In vivo bioimaging rats for translational research in cell and tissue transplantation Cell Med 3 2012 3 11
31. K. Negishi, T. Teratani, and J. Iwasaki et al. Luminescence technology in preservation and transplantation for rat islet Islets 3 2011 111 117
32. S.G. Ramella, A. Hadj-Aissa, and A. Barbieux et al. Evaluation of a high sodium-low potassium cold-storage solution by the isolated perfused rat kidney technique Nephrol Dial Transplant 10 1995 842 846
33. J.P. Faure, H. Baumert, and Z. Han et al. Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass Biochem Pharmacol 66 2003 2241 2250
34. L. Brasile, B.M. Stubenitsky, and H. Maurits et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion Transplantation 73 2002 897 901
35. H. Ito, X. Yan, N. Nagata, and K. Aritake et al. PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis J Am Soc Nephrol 23 2012 1797 1809
36. S. Inoue, F.C. Popp, and G.E. Koehl et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model Transplantation 81 2006 1589 1595
37. S.P. Reddy, J. Brockmann, and P.J. Friend Normothermic perfusion: a mini-review Transplantation 87 2009 631 632
38. T.A. Berendsen, B.G. Bruinsma, and J. Lee et al. A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation Transplant Res 1 2012 6
39. L. Brasile, B.M. Stubenitsky, and M.H. Booster et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion Transplantation 73 2002 897 901
40. S.A. Hosgood, A.D. Barlow, and P.J. Yates et al. A pilot study assessing the feasibility of a short period of normothermic preservation in an experimental model of non heart beating donor kidneys J Surg Res 171 2011 283 290
41. S.A. Hosgood, and M.L. Nicholson First in man renal transplantation after ex vivo normothermic perfusion Transplantation 92 2011 735 758
42. M. Duijvestein, A.C. Vos, and H. Roelofs et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study Gut 59 2010 1662 1669
43. R. Ciccocioppo, M.E. Bernardo, and A. Sgarella et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease Gut 60 2011 788 798
44. E. Eggenhofer, V. Benseler, and A. Kroemer et al. Mesechymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion Front Immunol 3 2012 297
45. M.J. Hoogduijn, M. Roemeling-van Rhijn, and A.U. Engela et al. Mesenchymal stem cells induce an inflammatory response after intravenous infusion [e-pub ahead of print] Stem Cells 2013 222825 222835
46. K. Le Blanc, F. Frassoni, and L. Ball et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 2008 1579 1586
47. K. Matsumoto, T. Yokoo, and H. Matsunari et al. Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue Stem Cells 30 2012 1228 1235
48. M.D. Kay, S.A. Hosgood, and S.J. Harper et al. Normothermic versus hypothermic ex vivo flush using a novel phosphate-free preservation solution (AQIX) in porcine kidneys J Surg Res 171 2011 275 282
49. T. Clausen, C. Van Hardeveld, and M.E. Everts Significance of cation transport in control of energy metabolism and thermogenesis Physiol Rev 71 1991 733 774
50. A. Banas, T. Teratani, and Y. Yamamoto et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury Stem Cells 26 2008 2705 2712
51. D. Thirabanjasak, K. Tantiwongse, and P.S. Thorner Angiomyeloproliferative lesions following autologous stem cell therapy J Am Soc Nephrol 21 2010 1218 1222
52. N. Wang, Q. Li, and L. Zhang et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6 PLoS One 7 2012 e43768
53. V. Ninichuk, O. Gross, and S. Segerer et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice Kidney Int 70 2006 121 129
54. S. Oyagi, M. Hirose, and M. Kojima et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats J Hepatol 44 2006 742 748